Literature DB >> 926318

Suppression of repeatedly occurring ventricular fibrillation with nifedipine in variant form of angina pectoris.

E Kimura, K Tanaka, K Mizuno, Y Honda, H Hashimoto.   

Abstract

It is reported that nifedipine, a newly developed antianginal agent, was dramatically effective to suppress the repeatedly occurring ventricular fibrillation in 2 cases of variant form of angina pectoris.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 926318     DOI： 10.1536/ihj.18.736

Source DB:  PubMed          Journal:  Jpn Heart J        ISSN： 0021-4868


  6 in total

Review 1.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

2.  Recent trends in the management of life-threatening ventricular arrhythmias.

Authors:  B N Singh; J N Weiss; K Nademanee; J H Wittig; P Guzy
Journal:  West J Med       Date:  1984-11

Review 3.  Role of calcium antagonists in cardiovascular therapy.

Authors:  H Dargie; E Rowland; D Krikler
Journal:  Br Heart J       Date:  1981-07

Review 4.  Verapamil in arrhythmia.

Authors:  D M Krikler
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

Review 5.  Calcium antagonists. Clinical use in the treatment of arrhythmias.

Authors:  B N Singh; K Nademanee; S H Baky
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

Review 6.  Clinical pharmacology of antiarrhythmic drugs.

Authors:  A Capucci; D Aschieri; G Q Villani
Journal:  Drugs Aging       Date:  1998-07       Impact factor: 3.923
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.